Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Immunis.AI Targets Late 2020 Prostate Cancer Risk Core Assay Launch

Immunis.AI Targets Late 2020 Prostate Cancer Risk Core Assay Launch

Jan 23, 2020
|
John Gilmore
Premium

NEW YORK – Immunogenomics startup Immunis.AI, once called OncoCell MDx, is eyeing the commercial launch of its prostate cancer surveillance laboratory-developed test, which leverages its immune-based liquip biopsy platform, by early 2021, the company said.

The Royal Oak, Michigan-based firm also aims to finalize an independent validation study for the prostate cancer signature assay within the next two months.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Genomic NFT

Nebula Genomics will be auctioning George Church's genome as a nonfungible token, according to The Scientist.

ACMG's Gregg Resigns

Anthony Gregg, the outgoing president of the American College of Medical Genetics and Genomics, has resigned after using racially insensitive language. 

Interaction Prediction

Facebook has developed an artificial intelligence approach to predict how drugs interact in cells, New Scientist reports.

PNAS Papers on TB in Tibet, Chemo-Induced Stress in Multiple Myeloma, Wasp Symbiont

In PNAS this week: adaptations among high-altitude Mycobacterium tuberculosis, response of multiple myeloma cells to chemotherapy-induced stress, and more.

Apr
22
Featured Webinar

Single-Cell Genomics Decodes the Developing Human Immune System

Sponsored by
10x Genomics

The human immune system is extremely complex, comprised of multiple cell types and states interacting in myriad ways to produce diverse cellular ecosystems.

Apr
29
Featured Webinar

A New Generation of PCR: At-home Testing and Preparing for Emerging Strains of COVID-19

Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

May
12
Featured Webinar

SARS-CoV-2 RNAemia Predicts Clinical Deterioration and Extrapulmonary Complications from COVID-19

Sponsored by
Combinati

This webinar will discuss a recent study that characterized the relationships between SARS-CoV-2 RNAemia and disease severity, clinical deterioration, and extrapulmonary complications (EPCs).

May
13
Featured Webinar

Limits of Detection Matter: New Challenges for SARS-CoV-2 Diagnostics and COVID-19 Patient Management

Sponsored by
LGC SeraCare Life Sciences

As we pass the one-year anniversary of both the COVID-19 pandemic and the first Emergency Use Authorized SARS-CoV-2 PCR detection assays, there remains significant opportunity for clinical laboratories to advance testing and support improved patient management.

What's Popular?

In Molecular Diagnostics

  1. European Union to Review Illumina's Planned Grail Acquisition Under New Guidance

  2. Columbia University-led Study Highlights Bionano Optical Genome Mapping Concordance with Cytogenetics

  3. Abbott Q1 Diagnostics Revenues More Than Double on COVID-19 Testing

  4. Sense Biodetection Raises $50M in Series B Financing to Develop POC MDx Platform, SARS-CoV-2 Test

  5. Korean Rare Disease Diagnostics Firm 3billion Looks to 2022 IPO, Expansion Into Drug Discovery

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.